APOA1 and Parkinson disease: This provides support to a growing consensus that both central brain and peripheral blood immune activation are relevant to PD and neurodegenerations.28, 39, 40, 41 We also found associations between reduced ApoA1 and higher CRP levels with worse baseline MDS‐UPDRS II.